Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06837181 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)

Study acronym: SPeCTRuM
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study sites: 6 to 18v4
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jun 1, 2025 to Sep 18, 2025
    • Site details revised at 6 of 6 sites
    v3
  3. Start date: Mar 1, 2025 to Jun 1, 2025
    • Eligibility criteria shortened, about 9 words
    • Study title shortened, about 4 words
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This multicenter cross-sectional study will include a diverse population of adolescents and adults with CF. The overall Aim is to describe prevalence of diabetes microvascular complications and macrovascular surrogates in people with established CFRD.
Trial Details
NCT Number NCT06837181
Lead Sponsor Jaeb Center for Health Research
Collaborators: Cystic Fibrosis Foundation
Conditions
(from sponsor)		 Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes, Diabetes, Retinopathy, Neuropathy, Nephropathy, Blood Pressure, Cardiovascular Risk +1 more
Related terms Cystic Fibrosis, Diabetes Complications, Diabetes Mellitus, Kidney Diseases, Retinal Diseases
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov